U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H27ClN2O.ClH
Molecular Weight 455.419
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LOFEPRAMINE HYDROCHLORIDE

SMILES

Cl.CN(CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2)CC(=O)C4=CC=C(Cl)C=C4

InChI

InChIKey=ZWZIQPOLMDPIQM-UHFFFAOYSA-N
InChI=1S/C26H27ClN2O.ClH/c1-28(19-26(30)22-13-15-23(27)16-14-22)17-6-18-29-24-9-4-2-7-20(24)11-12-21-8-3-5-10-25(21)29;/h2-5,7-10,13-16H,6,11-12,17-19H2,1H3;1H

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
LOFEPRAMINE HYDROCHLORIDE
JAN   MART.   MI   USAN   WHO-DD  
USAN  
Official Name English
4'-CHLORO-2-((3-(10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPIN-5-YL)PROPYL)METHYLAMINO)ACETOPHENONE MONOHYDROCHLORIDE
Systematic Name English
Lofepramine hydrochloride [WHO-DD]
Common Name English
LOFEPRAMINE HYDROCHLORIDE [MART.]
Common Name English
LOFEPRAMINE HYDROCHLORIDE [USAN]
Common Name English
ETHANONE, 1-(4-CHLOROPHENYL)-2-((3-(10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPIN-5-YL)PROPYL)METHYLAMINO)-, MONOHYDROCHLORIDE
Common Name English
LOFEPRAMINE HCL
Common Name English
4'-CHLORO-2-((3-(10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPIN-5-YL)PROPYL)METHYLAMINO)ACETOPHENONE HYDROCHLORIDE
Systematic Name English
AMPLIT
Brand Name English
LOFEPRAMINE HYDROCHLORIDE [MI]
Common Name English
WHR-2908A
Code English
LOFEPRAMINE HYDROCHLORIDE [JAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C265
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C87616
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
ECHA (EC/EINECS)
248-002-2
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
SMS_ID
100000087617
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
MERCK INDEX
m6884
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY Merck Index
CHEBI
31780
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
USAN
Y-39
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
FDA UNII
Z24K96F991
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
EPA CompTox
DTXSID9047833
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
RXCUI
6294
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY RxNorm
CAS
26786-32-3
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
PUBCHEM
33611
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
ChEMBL
CHEMBL87708
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
EVMPD
SUB02965MIG
Created by admin on Fri Dec 15 15:17:30 UTC 2023 , Edited by admin on Fri Dec 15 15:17:30 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of LOFEPRAMINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966